Pricing
Login
Home
Charts
Search
Watchlist
Products

Krebs Biochemicals & Industries Ltd

KREBSBIO
₹57.08-0.12%20 Nov 2026
Reports
Pharma CRAMS

Krebs Biochemicals & Industries Ltd

KREBSBIO
₹57.08
-0.12%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹123Cr
Close
Close Price
₹57.08
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
—
PS
Price To Sales
4.58
Revenue
Revenue
₹27Cr
Rev Gr TTM
Revenue Growth TTM
-1.36%
PAT Gr TTM
PAT Growth TTM
51.40%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
13121313116547776
Growth YoY
Revenue Growth YoY%
42.84.521.8-13.6-11.6-49.0-57.5-67.6-36.611.627.438.9
Expenses
ExpensesCr
151515161612877868
Operating Profit
Operating ProfitCr
-2-3-2-3-5-5-2-30-11-2
OPM
OPM%
-16.1-26.1-17.1-21.1-41.1-88.7-38.1-66.94.0-12.611.9-33.2
Other Income
Other IncomeCr
000000000200
Interest Expense
Interest ExpenseCr
111122222222
Depreciation
DepreciationCr
222222222222
PBT
PBTCr
-5-6-5-6-8-8-5-6-3-2-2-5
Tax
TaxCr
000000000000
PAT
PATCr
-5-6-5-6-8-8-5-6-3-2-2-5
Growth YoY
PAT Growth YoY%
10.315.73.0-61.3-55.4-41.4-2.9-6.659.671.753.412.1
NPM
NPM%
-38.4-48.9-40.1-44.8-67.5-135.6-97.1-147.2-43.0-34.4-35.5-93.3
EPS
EPS₹
-2.3-2.7-2.4-2.7-3.6-3.8-2.5-2.9-1.4-1.1-1.1-2.5
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
13121313116547776
Growth YoY
Revenue Growth YoY%
42.84.521.8-13.6-11.6-49.0-57.5-67.6-36.611.627.438.9
Expenses
ExpensesCr
151515161612877868
Operating Profit
Operating ProfitCr
-2-3-2-3-5-5-2-30-11-2
OPM
OPM%
-16.1-26.1-17.1-21.1-41.1-88.7-38.1-66.94.0-12.611.9-33.2
Other Income
Other IncomeCr
000000000200
Interest Expense
Interest ExpenseCr
111122222222
Depreciation
DepreciationCr
222222222222
PBT
PBTCr
-5-6-5-6-8-8-5-6-3-2-2-5
Tax
TaxCr
000000000000
PAT
PATCr
-5-6-5-6-8-8-5-6-3-2-2-5
Growth YoY
PAT Growth YoY%
10.315.73.0-61.3-55.4-41.4-2.9-6.659.671.753.412.1
NPM
NPM%
-38.4-48.9-40.1-44.8-67.5-135.6-97.1-147.2-43.0-34.4-35.5-93.3
EPS
EPS₹
-2.3-2.7-2.4-2.7-3.6-3.8-2.5-2.9-1.4-1.1-1.1-2.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1334483354605250432427
Growth
Revenue Growth%
152.4937.641.4-30.060.711.2-12.7-3.3-14.1-45.2-1.4
Expenses
ExpensesCr
141141585271946859582929
Operating Profit
Operating ProfitCr
-12-8-8-10-19-18-34-16-9-15-5-2
OPM
OPM%
-961.7-245.8-22.2-20.6-55.8-32.7-56.9-30.3-17.3-34.7-23.0-6.2
Other Income
Other IncomeCr
10-1001110122
Interest Expense
Interest ExpenseCr
135666535677
Depreciation
DepreciationCr
444455677766
PBT
PBTCr
-16-16-18-20-29-28-45-25-20-27-17-13
Tax
TaxCr
000000000000
PAT
PATCr
-16-16-18-20-29-28-45-25-20-27-17-13
Growth
PAT Growth%
-108.21.7-11.1-12.3-44.31.8-57.044.520.1-36.537.151.4
NPM
NPM%
-1,265.5-493.0-52.8-41.9-86.4-52.8-74.6-47.4-39.1-62.2-71.3-49.7
EPS
EPS₹
-12.8-8.1-13.5-12.8-17.9-14.4-20.8-11.3-9.2-12.5-7.8-6.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1334483354605250432427
Growth
Revenue Growth%
152.4937.641.4-30.060.711.2-12.7-3.3-14.1-45.2-1.4
Expenses
ExpensesCr
141141585271946859582929
Operating Profit
Operating ProfitCr
-12-8-8-10-19-18-34-16-9-15-5-2
OPM
OPM%
-961.7-245.8-22.2-20.6-55.8-32.7-56.9-30.3-17.3-34.7-23.0-6.2
Other Income
Other IncomeCr
10-1001110122
Interest Expense
Interest ExpenseCr
135666535677
Depreciation
DepreciationCr
444455677766
PBT
PBTCr
-16-16-18-20-29-28-45-25-20-27-17-13
Tax
TaxCr
000000000000
PAT
PATCr
-16-16-18-20-29-28-45-25-20-27-17-13
Growth
PAT Growth%
-108.21.7-11.1-12.3-44.31.8-57.044.520.1-36.537.151.4
NPM
NPM%
-1,265.5-493.0-52.8-41.9-86.4-52.8-74.6-47.4-39.1-62.2-71.3-49.7
EPS
EPS₹
-12.8-8.1-13.5-12.8-17.9-14.4-20.8-11.3-9.2-12.5-7.8-6.2
Sales CAGR
1 Year-45%
3 Years-23%
5 Years-15%
TTM-1%
Avg. ROCE
1 Year-16%
3 Years-23%
5 Years-30%
TTM-10%

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131414171820222222222222
Reserves
ReservesCr
-4-12-32-31-43-67-97-121-141-168-184-192
Current Liabilities
Current LiabilitiesCr
303242554348784962104113126
Non Current Liabilities
Non Current LiabilitiesCr
7489101102116154187225236212213203
Total Liabilities
Total LiabilitiesCr
116122126142134159190175178169163159
Current Assets
Current AssetsCr
9131731192135161710108
Non Current Assets
Non Current AssetsCr
107109109111115138154159161159154151
Total Assets
Total AssetsCr
116122126142134159190175178169163159
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131414171820222222222222
Reserves
ReservesCr
-4-12-32-31-43-67-97-121-141-168-184-192
Current Liabilities
Current LiabilitiesCr
303242554348784962104113126
Non Current Liabilities
Non Current LiabilitiesCr
7489101102116154187225236212213203
Total Liabilities
Total LiabilitiesCr
116122126142134159190175178169163159
Current Assets
Current AssetsCr
9131731192135161710108
Non Current Assets
Non Current AssetsCr
107109109111115138154159161159154151
Total Assets
Total AssetsCr
116122126142134159190175178169163159

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-15-11-64-36-15-17-252-8-2
Investing Cash Flow
Investing Cash FlowCr
-4-5-3-4-10-23-23-13-8-5-4
Financing Cash Flow
Financing Cash FlowCr
1316917293840376136
Net Cash Flow
Net Cash FlowCr
-60017-171-10000
Free Cash Flow
Free Cash FlowCr
-13-22-100-44-32-44-40-5-11-5
CFO To PAT
CFO To PAT%
93.569.834.7-19.5123.051.438.7100.1-12.029.311.3
CFO To EBITDA
CFO To EBITDA%
123.1140.082.5-39.7190.582.950.6156.6-27.152.535.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-15-11-64-36-15-17-252-8-2
Investing Cash Flow
Investing Cash FlowCr
-4-5-3-4-10-23-23-13-8-5-4
Financing Cash Flow
Financing Cash FlowCr
1316917293840376136
Net Cash Flow
Net Cash FlowCr
-60017-171-10000
Free Cash Flow
Free Cash FlowCr
-13-22-100-44-32-44-40-5-11-5
CFO To PAT
CFO To PAT%
93.569.834.7-19.5123.051.438.7100.1-12.029.311.3
CFO To EBITDA
CFO To EBITDA%
123.1140.082.5-39.7190.582.950.6156.6-27.152.535.2

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
13713822619314717430912213214486123
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
106.342.26.74.04.43.35.22.32.63.33.64.6
Price To Book
Price To Book
14.793.6-12.7-13.5-5.9-3.7-4.1-1.2-1.1-1.0-0.5-0.7
EV To EBITDA
EV To EBITDA
-13.1-22.5-36.9-23.0-11.4-16.2-13.3-19.3-37.2-23.7-57.1-210.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
-259.617.323.218.61.52.7-21.58.623.915.345.745.7
OPM
OPM%
-961.7-245.8-22.2-20.6-55.8-32.7-56.9-30.3-17.3-34.7-23.0-6.2
NPM
NPM%
-1,265.5-493.0-52.8-41.9-86.4-52.8-74.6-47.4-39.1-62.2-71.3-49.7
ROCE
ROCE%
-45.0-28.4-37.4-38.3-56.6-34.7-57.7-25.9-20.3-31.9-15.9-10.4
ROE
ROE%
-174.7-1,086.7100.3140.1115.560.559.324.816.618.410.47.8
ROA
ROA%
-14.0-13.2-14.2-14.1-21.6-17.8-23.5-14.1-11.1-15.9-10.4-8.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
13713822619314717430912213214486123
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
106.342.26.74.04.43.35.22.32.63.33.64.6
Price To Book
Price To Book
14.793.6-12.7-13.5-5.9-3.7-4.1-1.2-1.1-1.0-0.5-0.7
EV To EBITDA
EV To EBITDA
-13.1-22.5-36.9-23.0-11.4-16.2-13.3-19.3-37.2-23.7-57.1-210.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
-259.617.323.218.61.52.7-21.58.623.915.345.745.7
OPM
OPM%
-961.7-245.8-22.2-20.6-55.8-32.7-56.9-30.3-17.3-34.7-23.0-6.2
NPM
NPM%
-1,265.5-493.0-52.8-41.9-86.4-52.8-74.6-47.4-39.1-62.2-71.3-49.7
ROCE
ROCE%
-45.0-28.4-37.4-38.3-56.6-34.7-57.7-25.9-20.3-31.9-15.9-10.4
ROE
ROE%
-174.7-1,086.7100.3140.1115.560.559.324.816.618.410.47.8
ROA
ROA%
-14.0-13.2-14.2-14.1-21.6-17.8-23.5-14.1-11.1-15.9-10.4-8.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr230149128123908072
Close PriceClose₹207.00135.00158.0057.0868.5152.7539.45
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.2443.83
Price To SalesPS2.281.091.834.580.931.230.91
RevenueRevenueCr1011377027976578
Revenue Growth TTMRev Gr TTM%22.3%54.7%-1.4%114.4%17.9%
PAT Growth TTMPAT Gr TTM%44.5%-3.4%51.4%410.3%52.3%
Market CapitalizationMkt CapCr230149128123908072
Close PriceClose₹207.00135.00158.0057.0868.5152.7539.45
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.2443.83
Price To SalesPS2.281.091.834.580.931.230.91
RevenueRevenueCr1011377027976578
Revenue Growth TTMRev Gr TTM%22.3%54.7%-1.4%114.4%17.9%
PAT Growth TTMPAT Gr TTM%44.5%-3.4%51.4%410.3%52.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews